Multi-D Treatment of High Risk Soft Tissue Sarcomas

10/15/2008 - Webcast

Guests Include:

Expert: James Hayden, M.D., Ph.D.
Dr. James Hayden obtained both his medical and post doctorate degrees from Oregon Health & Sciences University where he also did his Residency in Orthopaedic Surgery. It was at Massachusetts General Hospital in Boston where he received his fellowship in Musculoskeletal Oncology. He joined the OHSU Department of Orthopaedics & Rehabilitation in 2002 and is currently an Assistant Professor. Dr. Hayden’s research and clinical interests include bone tumors, soft tissue neoplasms, inflammatory arthropathies, and metabolic bone disease.

Patient: Patricia Beck

Download MP3 Listen to Streaming Audio Download Transcript

Soft tissue sarcomas are relatively uncommon cancers. They account for less than 1% of all new cancer cases each year. As the only fully functional sarcoma team between Seattle, San Francisco and Salt Lake City, Oregon Health & Sciences University sees over 350 new tumor patients per year. For better insight on this topic, Dr. James Hayden joins this webcast to discuss the multi-disciplinary treatment of high risk soft tissue sarcomas.

Dr. Hayden will help us understand how programs like one at Oregon Health & Science University are giving many patients a renewed hope through their coordinated care approach.
We will also be hearing from Patricia Beck, who was diagnosed with soft tissue sarcoma, and a patient of Dr. Hayden’s.